Page 2 - Csaba Kantor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Csaba kantor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Csaba Kantor Today - Breaking & Trending Today

Glenmark Pharma's Ryaltris gets approval in Russia


The drug maker announced that its Swiss subsidiary, Glenmark Specialty S.A., received marketing approval from the Ministry of Health of the Russian Federation for Ryaltris nasal spray.Ryaltris (olopatadine hydrochloride 665 mcg and mometasone furoate 25 mcg), is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age. Ryaltris relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and watery eyes.
This approval paves the way for commercialization of Ryaltris in Russia, which is expected to be made available to patients in the country in Q1 FY 2021-22. ....

Csaba Kantor , Glenmark Pharmaceuticals , Russian Federation , Capital Market , Medical Specialties , Clinical Medicine , Nasal Spray , Olopatadine Mometasone , Mast Cell Stabilizers , Allergic Rhinitis , Russian Federation For Ryaltris , Seasonal And Perennial , க்ளேண்மர்க் மருந்துகள் , ரஷ்ய கூட்டமைப்பு , மூலதனம் சந்தை , மருத்துவ சிறப்பு , மருத்துவ மருந்து , நாசி தெளிப்பு , மாஸ்ட் செல் நிலைப்படுத்திகள் , பருவகால மற்றும் வற்றாத ,